Waterloo Capital, L.P. Abbott Laboratories Transaction History
Waterloo Capital, L.P.
- $783 Billion
- Q1 2024
A detailed history of Waterloo Capital, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Waterloo Capital, L.P. holds 6,376 shares of ABT stock, worth $662,593. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,376
Previous 6,623
3.73%
Holding current value
$662,593
Previous $729 Million
0.59%
% of portfolio
0.09%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,114Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.2 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.8 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.73 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.77 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.29 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...